These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3404765)
21. Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models. Zhenjiu W; Awaji T; Hirasawa A; Motomura S; Hashimoto K Mol Cell Biochem; 1993 Feb; 119(1-2):159-69. PubMed ID: 8455577 [TBL] [Abstract][Full Text] [Related]
22. [Effects of a new antiarrhythmic drug, KW-3407, on canine ventricular arrhythmia models]. Wu Z; Awaji T; Motomura S; Hashimoto K Nihon Yakurigaku Zasshi; 1992 Aug; 100(2):117-26. PubMed ID: 1427497 [TBL] [Abstract][Full Text] [Related]
23. Effects of a new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models. Hashimoto K; Sugiyama A; Haruno A; Matsuzaki T; Hirasawa A J Cardiovasc Pharmacol; 1991 Feb; 17(2):336-42. PubMed ID: 1709241 [TBL] [Abstract][Full Text] [Related]
24. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110 [TBL] [Abstract][Full Text] [Related]
25. Effective plasma concentrations of aprindine in canine ventricular arrhythmias. Hashimoto K; Komori S; Ishii M; Kamiya J J Cardiovasc Pharmacol; 1984; 6(1):12-9. PubMed ID: 6199593 [TBL] [Abstract][Full Text] [Related]
26. Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog. Haruno A; Hashimoto K Jpn J Pharmacol; 1995 May; 68(1):95-102. PubMed ID: 7494388 [TBL] [Abstract][Full Text] [Related]
27. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ. Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766 [TBL] [Abstract][Full Text] [Related]
28. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs. Shibuya T; Hashimoto K; Imai S J Cardiovasc Pharmacol; 1983; 5(4):538-45. PubMed ID: 6193348 [TBL] [Abstract][Full Text] [Related]
29. Antiarrhythmic plasma concentrations of mexiletine on canine ventricular arrhythmias. Hashimoto K; Ishii M; Komori S J Cardiovasc Pharmacol; 1984; 6(2):213-9. PubMed ID: 6200706 [TBL] [Abstract][Full Text] [Related]
30. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs. Yoshimura A; Yoshioka K; Hino M; Sugawara H; Sakato M; Endoh M Arzneimittelforschung; 1999 May; 49(5):420-6. PubMed ID: 10367104 [TBL] [Abstract][Full Text] [Related]
31. Effects of dofetilide, a class III antiarrhythmic drug, on various ventricular arrhythmias in dogs. Chen J; Xue Y; Eto K; Ni C; Hashimoto K J Cardiovasc Pharmacol; 1996 Oct; 28(4):576-84. PubMed ID: 8891885 [TBL] [Abstract][Full Text] [Related]
32. Antiarrhythmic effects of optical isomers of disopyramide on canine ventricular arrhythmias. Nakamura M; Xue Y; Eto K; Hashimoto K J Cardiovasc Pharmacol; 1996 Mar; 27(3):368-75. PubMed ID: 8907798 [TBL] [Abstract][Full Text] [Related]
33. Relationships between ventricular arrhythmias and plasma concentrations of ME3202 (CM7857) in dogs. Hashimoto K; Ishii M; Watanabe K J Cardiovasc Pharmacol; 1989 Jul; 14(1):121-6. PubMed ID: 2475703 [TBL] [Abstract][Full Text] [Related]
34. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia. Hashimoto K; Satoh H; Shibuya T; Imai S J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241 [TBL] [Abstract][Full Text] [Related]
35. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models. Xue Y; Tanabe S; Nabuchi Y; Hashimoto K J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986 [TBL] [Abstract][Full Text] [Related]
36. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362). Bergey JL; Sulkowski T; Much DR; Wendt RL Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506 [TBL] [Abstract][Full Text] [Related]